Relapse-markers
Showing 1 - 25 of >10,000
Belief-updating, Speech and Psychosis
Not yet recruiting
- Psychosis
- (no location specified)
Sep 15, 2023
Alcohol Use Disorder Trial (Online survey)
Not yet recruiting
- Alcohol Use Disorder
- Online survey
- (no location specified)
Jul 7, 2022
Relapse Markers for Colorectal Cancer
Recruiting
- Colorectal Cancer
-
Leuven, BelgiumDepartment of Gastroenterology, Digestive Oncology Unit
Jun 9, 2021
Disease Bowel, Crohn Disease, Ulcerative Colitis Trial in France (Sleep activity, Questionnaires)
Not yet recruiting
- Disease Bowel
- +2 more
- Sleep activity
- Questionnaires
-
Clermont-Ferrand, France
- +3 more
Apr 28, 2023
Blood Pressure, Dyslipidemias, Dysglycemia Trial (Snus with or without tobacco)
Not yet recruiting
- Blood Pressure
- +3 more
- Snus with or without tobacco
- (no location specified)
Sep 2, 2023
Search for BIO Diagnostic and Prognostic Markers in Adult
Recruiting
- Vasculitis
- Sampling
-
Tours, FranceUniversity hospital
Jan 9, 2023
Protracted Bacterial Bronchitis Trial in Stavanger (Amoxicillin-Clavulanate 400 Mg-57 Mg/5 mL Oral Powder for Reconstitution,
Recruiting
- Protracted Bacterial Bronchitis
- Amoxicillin-Clavulanate 400 Mg-57 Mg/5 mL Oral Powder for Reconstitution
- Placebo
-
Stavanger, NorwayStavanger University Hospital
Aug 28, 2023
Imaging Features in Invasiveness and Prognosis of Pituitary
Recruiting
- Pituitary Adenoma
- Neuroendocrine Tumors
- diagnosed and treated reasonably according to the clinical guidelines and clinical pathways
-
Guangzhou, Guangdong, Chinaendocrinology department of the first affiliated hospital of Sun
Aug 24, 2023
Transplant; Failure, Liver, Addiction, Alcohol Trial in Montpellier (Addiction follow-up before and after liver transplantation)
Recruiting
- Transplant; Failure, Liver
- Addiction, Alcohol
- Addiction follow-up before and after liver transplantation
-
Montpellier, Occitanie, FranceDepartment of hepato-gastroenterology and liver transplantation
Aug 1, 2022
Clinical Prognostic Score to Predict Relapse in VL
Not yet recruiting
- Visceral Leishmaniasis
- No intervention
- (no location specified)
Nov 3, 2022
Improving Diagnosis and Prognosis of Endometriosis. (ENDOBIO)
Not yet recruiting
- Endometriosis
- Blood biomarkers
- (no location specified)
Oct 24, 2022
Prostate Cancer to Identify Predictive Markers of Disease
Unknown status
- Prostatic Neoplasms
-
Lille, FranceHôpital Claude Huriez, CHRU
Nov 6, 2019
Substance Abuse Disorder Trial in Morgantown (PRSS (Peer Recovery Support Specialist))
Recruiting
- Substance Abuse Disorder
- PRSS (Peer Recovery Support Specialist)
-
Morgantown, West VirginiaWest Virginia University Rockefeller Neuroscience Institute
Jul 27, 2023
Multiple Sclerosis Trial in Haifa (Diagnosis, skin volatile organic compounds (VOCs))
Completed
- Multiple Sclerosis
- Diagnosis, skin volatile organic compounds (VOCs)
-
Haifa, IsraelAriel Miller
Dec 6, 2022
MDS, Acute Myeloid Leukemia With Myelodysplasia Related Disease and < 30% Blasts, Mixed Myelodysplastic/Myeloproliferative
Recruiting
- Myelodysplastic Syndromes
- +2 more
- Azacitidine
- +2 more
-
Stockholm, SwedenDepartment of Hematology, Karolinska University Hospital
Mar 27, 2023
Cancer Colorectal Trial (a multi-locus blood-based assay)
Not yet recruiting
- Cancer Colorectal
- a multi-locus blood-based assay
- (no location specified)
Sep 7, 2022
Crohn's Disease Trial in Edmonton (Synbiotic, Digestible Maltodextrin)
Recruiting
- Crohn's Disease
- Synbiotic
- Digestible Maltodextrin
-
Edmonton, Alberta, Canada
- +4 more
Jan 10, 2023
Novel Digital Array PCR for Acute Myeloid Leukemia (AML)
Recruiting
- Leukemia, Myeloid, Acute
- Minimal Residual Disease
-
Chapel Hill, North CarolinaNorth Carolina Cancer Hospital (NCCH)
Feb 2, 2023
Neuroinflammation Markers in Subjects With Psychotic Symptoms
Recruiting
- Neuroinflammatory Response
- Psychosis
-
Málaga, SpainHospital Regional Universitario de Málaga
Apr 3, 2023
Inflammatory Marker in Ibd and Peripheral Arthritis
Not yet recruiting
- IBD-Inflammatory Bowel Disease
- (no location specified)
Jan 20, 2023
AML/MDS Trial in Copenhagen (iDLI)
Recruiting
- AML/MDS
- iDLI
-
Copenhagen, DenmarkCopenhagen University Hospital, Rigshospitalet
Jan 13, 2023
Insulin Resistance in Egyptian Patients With Multiple Sclerosis
Not yet recruiting
- Multiple Sclerosis
- Insulin Resistance
- treatment of insulin resistance with appropriate modality according to each patient
- (no location specified)
Aug 28, 2023
Relapsed Adult AML Trial in Germany (Venetoclax Oral Tablet)
Recruiting
- Relapsed Adult AML
- Refractory AML
- Venetoclax Oral Tablet
-
Augsburg, Germany
- +11 more
Jan 11, 2023
Deficient T Regulatory Cell Function in Relapsing Remitting
Recruiting
- Relapse Remitting Multiple Sclerosis
-
Philadelphia, PennsylvaniaThomas Jefferson University
Jun 13, 2022